Your browser doesn't support javascript.
loading
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.
Yan, X Q; Ye, M J; Zou, Q; Chen, P; He, Z S; Wu, B; He, D L; He, C H; Xue, X Y; Ji, Z G; Chen, H; Zhang, S; Liu, Y P; Zhang, X D; Fu, C; Xu, D F; Qiu, M X; Lv, J J; Huang, J; Ren, X B; Cheng, Y; Qin, W J; Zhang, X; Zhou, F J; Ma, L L; Guo, J M; Ding, D G; Wei, S Z; He, Y; Guo, H Q; Shi, B K; Liu, L; Liu, F; Hu, Z Q; Jin, X M; Yang, L; Zhu, S X; Liu, J H; Huang, Y H; Xu, T; Liu, B; Sun, T; Wang, Z J; Jiang, H W; Yu, D X; Zhou, A P; Jiang, J; Luan, G D; Jin, C L; Xu, J.
Affiliation
  • Yan XQ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital & Institute, Beijing.
  • Ye MJ; Department of Urology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha.
  • Zou Q; Department of Urology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing.
  • Chen P; Department of Urology, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi.
  • He ZS; Department of Urology, First Hospital of Peking University, Beijing.
  • Wu B; Department of Urology, Shengjing Hospital of China Medical University, Shenyang.
  • He DL; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an.
  • He CH; Department of Urology, Cancer Hospital of Henan Province, Zhengzhou.
  • Xue XY; Department of Urology, The First Affiliated Hospital, Fujian Medical University, Fuzhou.
  • Ji ZG; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
  • Chen H; Department of Urology, Harbin Medical University Cancer Hospital, Harbin.
  • Zhang S; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu.
  • Liu YP; Department of Oncology, The First Hospital of China Medical University, Shenyang.
  • Zhang XD; Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing.
  • Fu C; Department of Urology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang.
  • Xu DF; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai.
  • Qiu MX; Department of Urology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu.
  • Lv JJ; Department of Urology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan.
  • Huang J; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou.
  • Ren XB; Department of Immunology and Biotherapy, Cancer Institute & Hospital, Tianjin Medical University, Tianjin.
  • Cheng Y; Department of Medical Thoracic Oncology, Jilin Provincial Cancer Hospital, Changchun.
  • Qin WJ; Department of Urology, Xijing Hospital of Air Force Military Medical University, Xi'an.
  • Zhang X; Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing.
  • Zhou FJ; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou.
  • Ma LL; Department of Urology, Peking University Third Hospital, Beijing.
  • Guo JM; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai.
  • Ding DG; Department of Urology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou.
  • Wei SZ; Department of Urology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
  • He Y; Department of Urology, The Affiliated Hospital of Jiaxing University, Jiaxing.
  • Guo HQ; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing.
  • Shi BK; Department of Urology, Qilu Hospital of Shandong University, Jinan.
  • Liu L; Department of Urology, Qilu Hospital of Shandong University, Jinan.
  • Liu F; Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou.
  • Hu ZQ; Department of Urology, Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan.
  • Jin XM; Department of Oncology, General Hospital of Ningxia Medical University, Yinchuan.
  • Yang L; Department of Urology, The Second Hospital of Lanzhou University, Lanzhou.
  • Zhu SX; Department of Urology, Fujian Medical University Union Hospital, Fuzhou.
  • Liu JH; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming.
  • Huang YH; Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou.
  • Xu T; Department of Urology, Peking University People's Hospital, Beijing.
  • Liu B; Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou.
  • Sun T; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang.
  • Wang ZJ; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing.
  • Jiang HW; Department of Urology, Huashan Hospital, Fudan University, Shanghai.
  • Yu DX; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei.
  • Zhou AP; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
  • Jiang J; Department of Urology, The PLA General Hospital Army Characteristic Medical Center, Chongqing.
  • Luan GD; Shanghai Junshi Biosciences Co., Ltd., Shanghai.
  • Jin CL; Shanghai Junshi Biosciences Co., Ltd., Shanghai.
  • Xu J; Shanghai Junshi Biosciences Co., Ltd., Shanghai.
Ann Oncol ; 35(2): 190-199, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37872020
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antibodies, Monoclonal, Humanized / Kidney Neoplasms Limits: Humans Language: En Journal: Ann Oncol Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antibodies, Monoclonal, Humanized / Kidney Neoplasms Limits: Humans Language: En Journal: Ann Oncol Year: 2024 Document type: Article